Increased incidence and severity of the systemic inflammatory syndrome in patients deficient in mannose-binding lectin

Intensive Care Medicine

Volumn 30, Issue 7, 2004, Pages 1438-1445

  Fidler, Katy J ^a   Wilson, Peter ^b   Davies, Jane C ^c   Turner, Malcolm W ^a   Peters, Mark J ^a   Klein, Nigel J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^c ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Complement; Mannose binding lectin; Sepsis; Systemic inflammatory response syndrome

Indexed keywords

MANNOSE BINDING LECTIN;

ADULT; AGED; ALLELE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DISEASE PREDISPOSITION; DISEASE SEVERITY; DNA POLYMORPHISM; EXON; FEMALE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN DEFICIENCY; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; EXONS; FEMALE; GREAT BRITAIN; HAPLOTYPES; HUMANS; INCIDENCE; INFANT; INTENSIVE CARE UNITS, PEDIATRIC; MALE; MANNOSE-BINDING LECTIN; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 3242700264     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Marshall JC (2001) Inflammation, coagulopathy, and the pathogenesis of multiple organ dysfunction syndrome. Crit Care Med 29:S99-S106
2. Vincent JL, Moreno R, Takala J, Willatts S, de Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG (1996) The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22:707-710
3. Crowther MA, Marshall JC (2001) Continuing challenges of sepsis research. JAMA 286:1894-1896
4. Opal SM, Cohen J (1999) Clinical gram-positive sepsis: does if fundamentally differ from gram-negative bacterial sepsis? Crit Care Med 27:1608-1616
5. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345:1368-1377
6. Van den BG, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R (2001) Intensive insulin therapy in the critically ill patients. N Engl J Med 345:1359-1367
7. Annane D, Sebille V, Charpentier C, Bollaert PE, Francois B, Korach JM, Capellier G, Cohen Y, Azoulay E, Troche G et al (2002) Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288:862-871
8. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW et al (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344:699-709
9. Turner MW (1996) Mannose binding lectin: the pluripotent molecule of the innate immune system. Immunol Today 17:532-540
10. Kuhlman M, Joiner K, Ezekowitz RA (1989) The human mannose-binding protein functions as an opsonin. J Exp Med 169:1733-1745
11. Tenner AJ, Robinson SL, Ezekowitz RAB (1995) Mannose-binding protein (MBP) enhances mononuclear phagocyte function via a receptor that contains the 126:000 m(r) component of the C1q receptor. Immunity 3:485-493
12. Jack DL, Read RC, Tenner AJ, Frosch M, Turner MW, Klein NJ (2001) Mannose-binding lectin regulates the inflammatory response of human professional phagocytes to Neisseria meningitidis serogroup B. J Infect Dis 184:1152-1162
13. Super M, Thiel S, Lu J, Levinsky RJ, Turner MW (1989) Association of low levels of mannan-binding protein with a common defect of opsonisation. Lancet II:1236-1239
14. Lipscombe RJ, Sumiya M, Summerfield JA, Turner MW (1995) Distinct physicochemical characteristics of human mannose binding protein expressed by individuals of differing genotype. Immunology 85:660-667
15. Madsen HO, Garred P, Thiel S, Kurtzhals JAL, Lamm LU, Ryder LP, Svejgaard A (1995) Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol 155:3013-3020
16. Madsen HO, Satz ML, Hogh B, Svejgaard A, Garred P (1998) Different molecular events result in low protein levels of mannan-binding lectin in populations from Southeast Africa and South America. J Immunol 161:3169-3175
17. Koch A, Melbye M, Sørensen P, Homøe P, Madsen HO, Mølbak K, Hansen CH, Andersen LH, Hahn GW, Garred P (2001) Acute respiratory tract infections and mannose-binding lectin insufficiency during early childhood. JAMA 285:1316-1321
18. Neth O, Hann I, Turner MW, Klein NJ (2001) Deficiency of mannose-binding lectin and burden of infection in children with malignancy: a prospective study. Lancet 358:614-618
19. Summerfield JA, Sumiya M, Levin M, Turner MW (1997) Association of mutations in mannose binding protein gene with childhood infection in consecutive hospital series. BMJ 314:1229-1232
20. Peterslund NA, Koch C, Jensenius JC, Thiel S (2001) Association between deficiency of mannose-binding lectin and severe infections after chemotherapy. Lancet 358:637-638
21. Santos IK, Costa CH, Krieger H, Feitosa MF, Zurakowski D, Fardin B, Gomes RB, Weiner DL, Harn DA, Ezekowitz RA et al (2001) Mannan-binding lectin enhances susceptibility to visceral leishmaniasis. Infect Immun 69:5212-5215
22. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644-1655
23. Hayden WR (1993) Sepsis and organ failure definitions and guidelines. Crit Care Med 21:1612-1613
24. Shann F, Pearson G, Slater A, Wilkinson K (1997) Paediatric index of mortality (PIM): a mortality prediction model for children in intensive care. Intensive Care Med 23:201-207
25. Leteurtre S, Martinot A, Duhamel A, Gauvin F, Grandbastien B, Nam TV, Proulx F, Lacroix J, Leclerc F (1999) Development of a pediatric multiple organ dysfunction score: use of two strategies. Med Decis Making 19:399-410
26. Jack D, Bidwell J, Turner M, Wood N (1997) Simultaneous genotyping for all three known structural mutations in the human mannose-binding lectin gene. Hum Mutat 9:41-46
27. Turner MW, Dinan L, Heatley S, Jack DL, Boettcher B, Lester S, McCluskey J, Roberton DM (2000) Restricted polymorphism of the mannose-binding lectin gene of indigenous Australians. Hum Mol Genet 9:1481-1486
28. Mead R, Jack D, Pembrey M, Tyfield L, Turner M and the ALSPAC Study Team (1997) Mannose-binding lectin alleles in a prospectively recruited UK population. Lancet 349:1669-1670
29. Reid CL, Perrey C, Pravica V, Hutchinson IV, Campbell IT (2002) Genetic variation in proinflammatory and anti-inflammatory cytokine production in multiple organ dysfunction syndrome. Crit Care Med 30:2216-2221
30. Stuber F, Petersen M, Bokelmann F, Schade U (1996) A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis. Crit Care Med 24:381-384
31. Slutsky AS, Russell J (2002) Genetics of critical illness: methodological issues. Crit Care Med 30:2382-2383
32. Garred P, Strom J, Quist L, Taaning E, Madsen HO (2003) Association of mannose-binding lectin polymorphisms with sepsis and fatal outcome, in patients with systemic inflammatory response syndrome. J Infect Dis 188:1394-1403
33. Jordan JE, Montalto MC, Stahl GL (2001) Inhibition of mannose-binding lectin reduces postischemic myocardial reperfusion injury. Circulation 104:1413-1418
34. Garred P, Richter C, Madsen HO, Mtoni I, Svejgaard A, Shao J (1997) Mannan-binding lectin in the sub-Saharan HIV and tuberculosis epidemics. Scand J Immunol 46:204-208
35. Brandtzaeg P, Hogasen K, Kierulf P, Mollnes TE (1996) The excessive complement activation in fulminant meningococcal septicemia is predominantly caused by alternative pathway activation. J Infect Dis 173:647-655
36. Garred P, Pressler T, Lanng S, Madsen HO, Moser C, Laursen I, Balstrup F, Koch C, Koch C (2002) Mannose-binding lectin (MBL) therapy in an MBL-deficient patient with severe cystic fibrosis lung disease. Pediatr Pulmonol 33:201-207